Logo image of HNR1.DE

HANNOVER RUECK SE (HNR1.DE) Stock Fundamental Analysis

Europe - FRA:HNR1 - DE0008402215 - Common Stock

249.8 EUR
+8.6 (+3.57%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to HNR1. HNR1 was compared to 40 industry peers in the Insurance industry. HNR1 has an excellent profitability rating, but there are some minor concerns on its financial health. HNR1 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

HNR1 had positive earnings in the past year.
HNR1 had a positive operating cash flow in the past year.
Each year in the past 5 years HNR1 has been profitable.
HNR1 had a positive operating cash flow in each of the past 5 years.
HNR1.DE Yearly Net Income VS EBIT VS OCF VS FCFHNR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

1.2 Ratios

The Return On Assets of HNR1 (3.58%) is better than 90.00% of its industry peers.
HNR1 has a Return On Equity of 22.37%. This is amongst the best in the industry. HNR1 outperforms 87.50% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.29%, HNR1 belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
HNR1 had an Average Return On Invested Capital over the past 3 years of 2.97%. This is in line with the industry average of 2.28%.
The 3 year average ROIC (2.97%) for HNR1 is below the current ROIC(4.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.58%
ROE 22.37%
ROIC 4.29%
ROA(3y)2.75%
ROA(5y)2.19%
ROE(3y)17.76%
ROE(5y)14.34%
ROIC(3y)2.97%
ROIC(5y)2.3%
HNR1.DE Yearly ROA, ROE, ROICHNR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of HNR1 (63.51%) is better than 97.50% of its industry peers.
In the last couple of years the Profit Margin of HNR1 has grown nicely.
The Operating Margin of HNR1 (87.59%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of HNR1 has grown nicely.
Industry RankSector Rank
OM 87.59%
PM (TTM) 63.51%
GM N/A
OM growth 3Y151.64%
OM growth 5Y62.65%
PM growth 3Y132.6%
PM growth 5Y58.31%
GM growth 3YN/A
GM growth 5YN/A
HNR1.DE Yearly Profit, Operating, Gross MarginsHNR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

The number of shares outstanding for HNR1 remains at a similar level compared to 1 year ago.
Compared to 5 years ago, HNR1 has less shares outstanding
The debt/assets ratio for HNR1 has been reduced compared to a year ago.
HNR1.DE Yearly Shares OutstandingHNR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HNR1.DE Yearly Total Debt VS Total AssetsHNR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

The Debt to FCF ratio of HNR1 is 0.78, which is an excellent value as it means it would take HNR1, only 0.78 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.78, HNR1 belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
A Debt/Equity ratio of 0.37 indicates that HNR1 is not too dependend on debt financing.
The Debt to Equity ratio of HNR1 (0.37) is better than 77.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 0.78
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
HNR1.DE Yearly LT Debt VS Equity VS FCFHNR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

HNR1 has a Current Ratio of 0.27. This is a bad value and indicates that HNR1 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Current ratio value of 0.27, HNR1 is doing good in the industry, outperforming 72.50% of the companies in the same industry.
A Quick Ratio of 0.27 indicates that HNR1 may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.27, HNR1 is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
HNR1.DE Yearly Current Assets VS Current LiabilitesHNR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.44% over the past year.
HNR1 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.64% yearly.
Looking at the last year, HNR1 shows a very strong growth in Revenue. The Revenue has grown by 36.77%.
The Revenue for HNR1 have been decreasing by -28.84% on average. This is quite bad
EPS 1Y (TTM)22.44%
EPS 3Y23.67%
EPS 5Y12.64%
EPS Q2Q%38.2%
Revenue 1Y (TTM)36.77%
Revenue growth 3Y-46.83%
Revenue growth 5Y-28.84%
Sales Q2Q%2%

3.2 Future

Based on estimates for the next years, HNR1 will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.07% on average per year.
The Revenue is expected to grow by 3.85% on average over the next years.
EPS Next Y12.69%
EPS Next 2Y8.36%
EPS Next 3Y6.59%
EPS Next 5Y8.07%
Revenue Next Year6.61%
Revenue Next 2Y4.63%
Revenue Next 3Y4.48%
Revenue Next 5Y3.85%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HNR1.DE Yearly Revenue VS EstimatesHNR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
HNR1.DE Yearly EPS VS EstimatesHNR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.14, the valuation of HNR1 can be described as correct.
Based on the Price/Earnings ratio, HNR1 is valued a bit cheaper than 67.50% of the companies in the same industry.
HNR1 is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.02 indicates a reasonable valuation of HNR1.
Based on the Price/Forward Earnings ratio, HNR1 is valued a bit more expensive than 60.00% of the companies in the same industry.
HNR1 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.14
Fwd PE 11.02
HNR1.DE Price Earnings VS Forward Price EarningsHNR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

HNR1's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HNR1 is cheaper than 72.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.72
EV/EBITDA N/A
HNR1.DE Per share dataHNR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

HNR1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HNR1 has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.96
PEG (5Y)0.96
EPS Next 2Y8.36%
EPS Next 3Y6.59%

5

5. Dividend

5.1 Amount

HNR1 has a Yearly Dividend Yield of 3.73%.
HNR1's Dividend Yield is slightly below the industry average, which is at 4.48.
HNR1's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 3.73%

5.2 History

The dividend of HNR1 has a limited annual growth rate of 5.92%.
Dividend Growth(5Y)5.92%
Div Incr Years4
Div Non Decr Years6
HNR1.DE Yearly Dividends per shareHNR1.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

45.20% of the earnings are spent on dividend by HNR1. This is a bit on the high side, but may be sustainable.
HNR1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP45.2%
EPS Next 2Y8.36%
EPS Next 3Y6.59%
HNR1.DE Yearly Income VS Free CF VS DividendHNR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
HNR1.DE Dividend Payout.HNR1.DE Dividend Payout, showing the Payout Ratio.HNR1.DE Dividend Payout.PayoutRetained Earnings

HANNOVER RUECK SE

FRA:HNR1 (9/12/2025, 7:00:00 PM)

249.8

+8.6 (+3.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners24.09%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.13B
Analysts78.26
Price Target294.03 (17.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.73%
Yearly Dividend7.57
Dividend Growth(5Y)5.92%
DP45.2%
Div Incr Years4
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.13%
Min EPS beat(2)-15.74%
Max EPS beat(2)1.47%
EPS beat(4)2
Avg EPS beat(4)-2%
Min EPS beat(4)-15.74%
Max EPS beat(4)18.73%
EPS beat(8)5
Avg EPS beat(8)1.35%
EPS beat(12)6
Avg EPS beat(12)-3.6%
EPS beat(16)8
Avg EPS beat(16)226.15%
Revenue beat(2)1
Avg Revenue beat(2)0.23%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)1.99%
Revenue beat(4)3
Avg Revenue beat(4)0.87%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)1.99%
Revenue beat(8)5
Avg Revenue beat(8)-1.22%
Revenue beat(12)6
Avg Revenue beat(12)-5.03%
Revenue beat(16)8
Avg Revenue beat(16)-8.13%
PT rev (1m)-0.76%
PT rev (3m)-0.02%
EPS NQ rev (1m)-3.87%
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.16%
EPS NY rev (3m)2.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 12.14
Fwd PE 11.02
P/S 7.71
P/FCF 5.72
P/OCF 5.72
P/B 2.72
P/tB 2.73
EV/EBITDA N/A
EPS(TTM)20.57
EY8.23%
EPS(NY)22.67
Fwd EY9.08%
FCF(TTM)43.65
FCFY17.48%
OCF(TTM)43.65
OCFY17.48%
SpS32.4
BVpS92
TBVpS91.35
PEG (NY)0.96
PEG (5Y)0.96
Profitability
Industry RankSector Rank
ROA 3.58%
ROE 22.37%
ROCE 4.96%
ROIC 4.29%
ROICexc 4.36%
ROICexgc 4.58%
OM 87.59%
PM (TTM) 63.51%
GM N/A
FCFM 134.74%
ROA(3y)2.75%
ROA(5y)2.19%
ROE(3y)17.76%
ROE(5y)14.34%
ROIC(3y)2.97%
ROIC(5y)2.3%
ROICexc(3y)3.02%
ROICexc(5y)2.35%
ROICexgc(3y)3.16%
ROICexgc(5y)2.55%
ROCE(3y)3.43%
ROCE(5y)2.66%
ROICexcg growth 3Y32.83%
ROICexcg growth 5Y11.08%
ROICexc growth 3Y40.56%
ROICexc growth 5Y15.67%
OM growth 3Y151.64%
OM growth 5Y62.65%
PM growth 3Y132.6%
PM growth 5Y58.31%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 0.78
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 10.94
Cash Conversion N/A
Profit Quality 212.15%
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)309.36%
Profit Quality(5y)334.25%
High Growth Momentum
Growth
EPS 1Y (TTM)22.44%
EPS 3Y23.67%
EPS 5Y12.64%
EPS Q2Q%38.2%
EPS Next Y12.69%
EPS Next 2Y8.36%
EPS Next 3Y6.59%
EPS Next 5Y8.07%
Revenue 1Y (TTM)36.77%
Revenue growth 3Y-46.83%
Revenue growth 5Y-28.84%
Sales Q2Q%2%
Revenue Next Year6.61%
Revenue Next 2Y4.63%
Revenue Next 3Y4.48%
Revenue Next 5Y3.85%
EBIT growth 1Y50.38%
EBIT growth 3Y33.8%
EBIT growth 5Y15.74%
EBIT Next Year8.15%
EBIT Next 3Y6.41%
EBIT Next 5YN/A
FCF growth 1Y-8.89%
FCF growth 3Y4.77%
FCF growth 5Y17.76%
OCF growth 1Y-8.89%
OCF growth 3Y4.77%
OCF growth 5Y17.76%